Filing Details

Accession Number:
0001102948-13-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-03 12:43:39
Reporting Period:
2013-08-05
Filing Date:
2013-09-03
Accepted Time:
2013-09-03 12:43:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1420720 Ibio Inc. IBIO Pharmaceutical Preparations (2834) 262797813
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1102948 Carl Desantis C/O Cds International Holdings
3299 Nw Second Ave
Boca Raton FL 33431
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-08-05 22,665 $0.51 6,544,555 No 4 S Indirect FN
Common Stock Disposition 2013-08-06 30,400 $0.50 6,514,155 No 4 S Indirect FN
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect FN
No 4 S Indirect FN
Footnotes
  1. Includes (i) 6,125 shares of common stock owned directly by the reporting person, (ii) 1,266,706 shares of common stock held by Integrated BioPharma, Inc. of which the reporting person is a controlling person, (iii) 1,530,563 shares of common stock held by CD Financial, LLC, and (iv) 3,710,761 shares of common stock held by the DeSantis Revocbale Trust (after accounting for the disposition of the 56,065 shares of common stock that are the subject of this report).